These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35184005)

  • 61. Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: An indirect comparison.
    Zhu LN; Chen D; Xu D; Tan G; Wang HJ; Liu L
    Seizure; 2017 Oct; 51():121-132. PubMed ID: 28854405
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Behavioural changes in patients with intellectual disability treated with brivaracetam.
    Andres E; Kerling F; Hamer H; Winterholler M
    Acta Neurol Scand; 2018 Sep; 138(3):195-202. PubMed ID: 29658982
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
    Klitgaard H; Matagne A; Nicolas JM; Gillard M; Lamberty Y; De Ryck M; Kaminski RM; Leclercq K; Niespodziany I; Wolff C; Wood M; Hannestad J; Kervyn S; Kenda B
    Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Usefulness of perampanel with concomitant levetiracetam for patients with drug-resistant epilepsy.
    Kanemura H; Sano F; Aihara M
    Eur J Paediatr Neurol; 2019 Jan; 23(1):197-203. PubMed ID: 30424990
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures.
    Mumoli L; Palleria C; Gasparini S; Citraro R; Labate A; Ferlazzo E; Gambardella A; De Sarro G; Russo E
    Drug Des Devel Ther; 2015; 9():5719-25. PubMed ID: 26543353
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long-term safety, efficacy, and quality of life during adjunctive brivaracetam treatment in patients with uncontrolled epilepsy: An open-label follow-up trial.
    Toledo M; Brandt C; Quarato PP; Schulz AL; Cleveland JM; Wagener G; Klein P
    Epilepsy Behav; 2021 May; 118():107897. PubMed ID: 33780735
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Potential role of brivaracetam in pediatric epilepsy.
    Verrotti A; Grasso EA; Cacciatore M; Matricardi S; Striano P
    Acta Neurol Scand; 2021 Jan; 143(1):19-26. PubMed ID: 32966640
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
    Shukla G; Gupta A; Agarwal P; Poornima S
    Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials.
    Ma J; Huang S; You C
    Epilepsy Res; 2015 Aug; 114():59-65. PubMed ID: 26088886
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial.
    O'Brien TJ; Borghs S; He QJ; Schulz AL; Yates S; Biton V
    Epilepsia; 2020 Apr; 61(4):636-646. PubMed ID: 32221987
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Brivaracetam augments short-term depression and slows vesicle recycling.
    Yang X; Bognar J; He T; Mohammed M; Niespodziany I; Wolff C; Esguerra M; Rothman SM; Dubinsky JM
    Epilepsia; 2015 Dec; 56(12):1899-909. PubMed ID: 26515103
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.
    Van Paesschen W; Hirsch E; Johnson M; Falter U; von Rosenstiel P
    Epilepsia; 2013 Jan; 54(1):89-97. PubMed ID: 22813235
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST).
    Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Irelli EC; Chiesa V; Dainese F; De Maria G; Didato G; Gennaro GD; Falcicchio G; Fanella M; Ferlazzo E; Gangitano M; La Neve A; Mecarelli O; Montalenti E; Morano A; Piazza F; Pizzanelli C; Pulitano P; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
    Seizure; 2022 Apr; 97():37-42. PubMed ID: 35320736
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Brivaracetam: First Canadian Experience in an Intractable Epilepsy Population.
    Lafortune J; Deacon C; Clément JF
    Can J Neurol Sci; 2020 Mar; 47(2):183-188. PubMed ID: 31685045
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety and tolerability of adjunctive brivaracetam in children with focal seizures: Interim analysis of pooled data from two open-label trials.
    Patel AD; Badalamenti V; Gasalla T; Elmoufti S; Elshoff JP
    Eur J Paediatr Neurol; 2020 Mar; 25():68-76. PubMed ID: 31810577
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A randomized, open-label, multicenter comparative trial of levetiracetam and topiramate as adjunctive treatment for patients with focal epilepsy in Korea.
    Lee SK; Lee SA; Kim DW; Loesch C; Pelgrims B; Osakabe T; Lee B;
    Epilepsy Behav; 2019 Aug; 97():67-74. PubMed ID: 31195326
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
    Brigo F; Bragazzi NL; Nardone R; Trinka E
    Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures.
    Toledo M; Whitesides J; Schiemann J; Johnson ME; Eckhardt K; McDonough B; Borghs S; Kwan P
    Epilepsia; 2016 Jul; 57(7):1139-51. PubMed ID: 27265725
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals.
    Strzelczyk A; Steinig I; Willems LM; Reif PS; Senft C; Voss M; Gaida B; von Podewils F; Rosenow F
    Epilepsy Behav; 2017 May; 70(Pt A):177-181. PubMed ID: 28427029
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy.
    Klein P; Biton V; Dilley D; Barnes M; Schiemann J; Lu S
    Epilepsia; 2016 Jul; 57(7):1130-8. PubMed ID: 27221208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.